Early studies in obese individuals showed some reductions in body fat mass, but findings are not consistent across trials: In one clinical trial, AOD9604 did not demonstrate statistically significant weight loss compared to placebo, suggesting its fat-burning effects may be modest without lifestyle intervention (summary of trials)
Phase 2: Days 16-30 (2 mg/day) From day 16 onward, the dose doubles to 8 units (2 mg per injection)
Yes, it provides powerful antioxidant protection with Glutathione
While IGF-I remains the biomarker that best reflects endogenous GH secretion, when there is a discordancy with GH and IGF-I levels, it is important for the clinician to be mindful of the associated changes in intra-portal insulin delivery to the liver when interpreting these results in the context of health and when deciding treatment regimens in disease states
Goldman reports
If you are seeking a proven treatment to revitalize your physical and mental well-being, consult with Dr
